Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00755820 · ClinicalTrials.gov registry record

Food Exposure Therapy in Anorexia Nervosa

A clinical trial of Anorexia Nervosa, sponsored by New York State Psychiatric Institute.

Completed
Registry status
32
Enrollment target
1
Study location

NCT00755820 is a study of Anorexia Nervosa that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 32 participants, below the 949-participant average among 43 other Anorexia Nervosa trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00755820, a study of Anorexia Nervosa, has completed, sponsored by New York State Psychiatric Institute.

COMPLETED
Registry status
32 participants
Enrollment target
1
Study location

Study Summary

This is a research study to determine whether a medication called D-cycloserine (DCS) in combination with a type of psychotherapy called Exposure Therapy is helpful to patients with anorexia nervosa.

Conditions Studied

Interventions

  • BEHAVIORAL Supportive Psychotherapy
  • BEHAVIORAL Exposure Therapy + D-Cycloserine
  • BEHAVIORAL Exposure Therapy + Placebo

Study Locations (1)

New York

  • New York State Psychiatric Institute - New York

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2008-01
Est. Completion 2012-01

What the Registry Record Tells You About NCT00755820

The ClinicalTrials.gov registry entry for NCT00755820 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 949-participant average among 43 other Anorexia Nervosa trials with a reported enrollment target (97% lower). The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Anorexia Nervosa appearing as the primary indexed condition, and to 3 interventions - of which Supportive Psychotherapy is the first listed.

NCT00755820 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT00755820 about?

NCT00755820 is a clinical study titled "Food Exposure Therapy in Anorexia Nervosa". This is a research study to determine whether a medication called D-cycloserine (DCS) in combination with a type of psychotherapy called Exposure Therapy is helpful to patients with anorexia nervosa.

What is the current status of trial NCT00755820?

This trial is currently completed. The enrollment target is 32 participants. The study started on 2008-01. Estimated completion is 2012-01.

What conditions does trial NCT00755820 study?

This clinical trial studies the following conditions: Anorexia Nervosa.

What interventions are being tested in trial NCT00755820?

The interventions under investigation include: Supportive Psychotherapy (BEHAVIORAL), Exposure Therapy + D-Cycloserine (BEHAVIORAL), Exposure Therapy + Placebo (BEHAVIORAL).

Who is sponsoring clinical trial NCT00755820?

This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00755820 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anorexia Nervosa

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.